• 19 deaths from liver drug causes Intercept shares to tumble pharmafile
    September 25, 2017
    Intercept Pharmaceuticals had sparked major concerns over its drug, Ocaliva, after it revealed that 10 people had died as a result of its treatment – that concerned escalated as the FDA announced 19 people in total had died.
PharmaSources Customer Service